AIG
CRNX icon

American International Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

American International Group’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,509
Closed -$1.52M – 645
2024
Q1 		$1.52M Buy
32,509
+52
+0.2% +$2.04K 0.01% 1097
2023
Q4 		$1.15M Buy
32,457
+207
+0.6% +$6.35K ﹤0.01% 1234
2023
Q3 		$959K Buy
32,250
+6,585
+26% +$136K 0.01% 1256
2023
Q2 		$462K Buy
25,665
+266
+1% +$5.3K ﹤0.01% 1690
2023
Q1 		$408K Buy
25,399
+506
+2% +$9.36K ﹤0.01% 1712
2022
Q4 		$456K Sell
24,893
-91
-0.4% -$1.6K ﹤0.01% 1644
2022
Q3 		$491K Buy
24,984
+354
+1% +$7.22K ﹤0.01% 1587
2022
Q2 		$459K Buy
24,630
+1,749
+8% +$34.9K ﹤0.01% 1657
2022
Q1 		$502K Sell
22,881
-1,611
-7% -$32.6K ﹤0.01% 1724
2021
Q4 		$696K Buy
24,492
+4,013
+20% +$98.9K ﹤0.01% 1620
2021
Q3 		$431K Buy
20,479
+40
+0.2% +$837 ﹤0.01% 1962
2021
Q2 		$385 Buy
20,439
+4,668
+30% +$82K ﹤0.01% 2089
2021
Q1 		$241 Buy
15,771
+41
+0.3% +$635 ﹤0.01% 2273
2020
Q4 		$222 Sell
15,730
-451
-3% -$6.28K ﹤0.01% 2226
2020
Q3 		$254K Sell
16,181
-368
-2% -$5.63K ﹤0.01% 1992
2020
Q2 		$290K Buy
16,549
+10,012
+153% +$171K ﹤0.01% 1900
2020
Q1 		$96K Sell
6,537
-377
-5% -$7.73K ﹤0.01% 2328
2019
Q4 		$173K Sell
6,914
-58
-0.8% -$1.1K ﹤0.01% 2302
2019
Q3 		$105K Sell
6,972
-50
-0.7% -$972 ﹤0.01% 2574
2019
Q2 		$176K Buy
7,022
+1,544
+28% +$38.2K ﹤0.01% 2309
2019
Q1 		$125K Buy
5,478
+893
+19% +$21.9K ﹤0.01% 2492
2018
Q4 		$138K Sell
4,585
-35
-0.8% -$985 ﹤0.01% 2410
2018
Q3 		$132K Buy
+4,620
New +$137K ﹤0.01% 2672

Other funds holding CRNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

American International Group's CRNX Position: Q2 2024 in Review

American International Group sold out of Crinetics Pharmaceuticals (CRNX) in Q2 2024, closing a stake of 32,509 shares — an estimated $1.52M sold.

American International Group first reported a position in CRNX in Q3 2018 and held it in 23 quarters. The position peaked at $1.52M in Q1 2024. 234 funds tracked by Wall St. Rank hold CRNX as of Q2 2024.

  • American International Group reported no remaining Crinetics Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 32,509 Crinetics Pharmaceuticals shares in Q2 2024, an estimated $1.52M.
  • American International Group first reported a position in Crinetics Pharmaceuticals in Q3 2018 and held it in 23 quarters.
  • American International Group's Crinetics Pharmaceuticals position peaked at $1.52M in Q1 2024.
  • 234 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.